DGAP-Adhoc: BB BIOTECH AG: Product approvals and solid company results lead the biotech sector higher
DGAP-Ad-hoc: BB BIOTECH AG / Key word(s): 9-month figures BB BIOTECH AG: Product approvals and solid company results lead the biotech sector higher 20-Oct-2017 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely ...